Pharmaceutical Companies have a quilted message for Washington: Don’t take us for granted. The industry’s lobbying group, PhRMA launched a new seven-figure ad campaign Tuesday. It was launched with the sentiment laid down across the top officials about a clear reminder of the industry’s role in developing medicines and vaccines for Covid-19.
The group is uncurling a new policy agenda that includes several unprecedented endorsements for drug pricing reforms that will ding industry profits. It differs from the scuffings of the existing policy as it focused more on competitors or tiny tweaks. The bearings are much smaller than the drug policy reforms being considered by the Democratic lawmakers. The new plank considered by the pharmaceutical industry will help pay for pricey injectable drugs. It will resemble that the industry is willing to engross a pay cut.
Pharmaceutical Companies are going through complicated phases as the lawmakers are posting the threat of making their policies and paying for the expensive drug prices. How the situation gets tackled is up to the industries, and we are sure that they will come out of it stronger.